PhRMA Sues Trump Administration Over Medicare Drug Price Pilot
PhRMA, the brand drug industry's main trade group, filed a lawsuit in the U.S. District Court for the District of Columbia against a Trump administration pilot program called GLOBE that ties Medicare Part B drug prices to prices paid in peer countries. The complaint argues the "most-favored nation" pilot exceeds Medicare's statutory authority. The pilot's practical impact is expected to be limited because the administration exempted all but a handful of companies in exchange for voluntary agreements to charge Medicaid most-favored-nation prices. The case was filed Wednesday.


